Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jul 1, 2011

Premium

Stephen Pennington and Michelle Cilia have been named the winners of the Integromics Proteomics Mass Spectrometry Research Grant competition, which aims to recognize creative use of the company's OmicsHub proteomics informatics tool. Both will receive a free one-year license to OmicsHub.

Pennington is a professor at University College Dublin. Under the grant he plans to work on improving clinical utility of mass spec-based protein biomarker assays.

Cilia is a scientist in the US Department of Agriculture's Agricultural Research Service and plans to use the grant in clinical validation studies of proteomic phenotypes developed for aphids and other insects that transmit plant viruses.


Jeffrey Peterson has joined Pressure BioSciences' board of directors.

Peterson is the CEO of Target Discovery. Previously he was CEO and general manager of Abbott South Africa. He was elected to the board contingent on the purchase of an aggregate of at least $500,000 worth of units in a private placement last week by Clayton Struve.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.